MarketsandMarkets Digital Event on Orphan Drugs and Rare Diseases( Time Zone - EASTERN STANDARD TIME (EST)

9 - 10 July 2020
CONFERENCE SPEAKERS
Speakers
Patricia Weltin
Patricia Weltin
CEO/Founder,
Beyond the Diagnosis



Scott Schliebner
Scott Schliebner
Senior Vice President, Center for Rare Diseases ,
PRA Health Sciences



Karen Frascello
Karen Frascello
Director, Global Medical Affairs, Early Access ,
Alnylam Pharmaceuticals



Dan Donovan
Dan Donovan
Founder & CEO ,
rareLife solutions



Dr. Michal Konstacky MD, PhD, MBA
Dr. Michal Konstacky MD, PhD, MBA
Global Medical Lead SHP 647 ,
Shire Pharmaceuticals



Stavros Ntogiakos
Stavros Ntogiakos
Regional Head of Rare Ocular Disease,
Novartis



Pedro Lendinez Ortega
Pedro Lendinez Ortega
Key Account Manager,
en Recordati Rare Diseases



Stephen Groft
Stephen Groft
Senior Advisor to the Director NCATS, ,
NIH



John Lagus
John Lagus
Managing Director of Business Development,
Tanner Pharma Group



Evelina Paberze
Evelina Paberze
Chief Operating Officer,
HRA Pharma Rare Diseases



Gregory R Stewart
Gregory R Stewart
PhD- Senior Vice President, Vector Delivery and Optimization,
Axovant Sciences



Monica Vinhas de Souza, MD, PhD
Monica Vinhas de Souza, MD, PhD
Executive Member of the research and ethics committee,
Hospital de ClĂ­nicas de Porto Alegre (HCPA)